article thumbnail

Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine

Bill Of Health

Regenerative medical technologies use cell- and tissue-based methods to recapitulate, bioengineer, and reprogram human tissue, making a whole suite of sci-fi-sounding technologies an ever-closer reality. It seems, in the near term, that the “who” would probably be a venture-backed biotechnology company — a corporate actor.

article thumbnail

Protecting the Consumer at the Heart of DTC Precision Medicine

Bill Of Health

The HIPAA Problem The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters. The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Governing Health Data for Research, Development, and Innovation: The Missteps of the European Health Data Space Proposal

Bill Of Health

By Enrique Santamaría Together with the Data Governance Act (DGA) and the General Data Protection Regulation (GDPR), the proposal for a Regulation on the European Health Data Space (EHDS) will most likely form the new regulatory and governance framework for the use of health data in the European Union. health data). If so, how?

article thumbnail

Petrie-Flom Welcomes 2022-2023 Student Fellows

Bill Of Health

These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. She has previously published articles on synthetic biology regulation and governance, end stage renal disease payment reform, and comparative analyses of learning disorder policy.

article thumbnail

AI in Digital Health: Autonomy, Governance, and Privacy

Bill Of Health

Trust and Design : Looking closely at data protection issues with a particular emphasis on questions of consent and trust in the context of the new data that is created by medical technologies.

article thumbnail

Reclaiming Global Public Health

Bill Of Health

New mRNA vaccines, underpinned by decades of public investment , had been authorized by global regulators. Patents and trade secrets empower private actors to make decisions about pricing, production, and supply of important medical technologies — in short, about public health.

article thumbnail

Egg Freezing in Israel: Legal Framework and Women’s Viewpoints

Bill Of Health

Giant corporations such as Apple and Facebook have offered funding for social egg freezing to their female employees while provoking ongoing bioethical and public debates regarding their implications, including; medicalization , (dis)empowerment , “appropriate” motherhood , medical risks, and success rates.